Technology can enrich the lives of those with low vision but a Michigan Medicine researcher says a policy change might address racial disparities in device use.

An innovative carotid procedure known as TCAR reverses blood flow to reduce stroke risk during revascularization. It’s now being performed at Michigan Medicine.

The novel platform for chemoimmunotherapy eliminated colon cancer in 85 percent of treated mice.

Some post-surgical patients can benefit from virtual appointments with a smartphone. Michigan Medicine is using the technology for this population.

Some taxis in the northern part of the country will soon have new passengers: pathology samples en route to labs for testing.

A new clinical trial is testing a catheter-based approach to treating mitral valve regurgitation, providing a faster procedure with a shorter recovery time.